Data / Form D filings / Icagen, Inc.
Icagen, Inc.: Form D filings
Icagen, Inc., a pharmaceuticals company in Durham, NC, filed 11 Form D notices with the SEC between 2011 and 2018. The latest, on September 12, 2018, reports $7.3 million sold of a $7.3 million offering to 1 investor.
Find out what Icagen, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4222 EMPEROR BLVD., SUITE 350, RESEARCH TRIANGLE PARK, Durham, NC, 27703
- Phone
- (919) 941-5206
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1518520
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 12, 2018 | New notice | $7,250,000 | $7,250,000 | $0 | 1 | Aug 31, 2018 | sec.gov |
| Aug 15, 2018 | New notice | $1,500,000 | $500,000 | $1,000,000 | 4 | Aug 13, 2018 | sec.gov |
| Apr 12, 2018 | New notice | $4,000,000 | $2,000,000 | $2,000,000 | 1 | Apr 4, 2018 | sec.gov |
| May 25, 2017 | New notice | $2,000,000 | $2,000,000 | $0 | 1 | May 15, 2017 | sec.gov |
| Apr 28, 2017 | New notice | $1,500,000 | $1,500,000 | $0 | 3 | Apr 12, 2017 | sec.gov |
| Jul 8, 2016 | New notice | $1,145,000 | $1,145,000 | $0 | 12 | Jun 27, 2016 | sec.gov |
| Jan 15, 2015 | Amendment | $8,855,000 | $8,855,000 | $0 | 162 | Dec 10, 2014 | sec.gov |
| Dec 16, 2014 | New notice | $7,875,000 | $49,000 | $7,826,000 | 2 | Dec 10, 2014 | sec.gov |
| May 10, 2013 | Amendment | $5,000,000 | $3,135,000 | $1,865,000 | 61 | Apr 17, 2013 | sec.gov |
| Apr 29, 2013 | New notice | $5,000,000 | $1,550,000 | $3,450,000 | 28 | Apr 17, 2013 | sec.gov |
| May 19, 2011 | New notice | $2,000,000 | $1,097,950 | $902,050 | 0 | May 13, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Vincent Palmieri | Director | |
| Timothy Tyson | Director | |
| Douglas Krafte | Executive Officer | |
| Mark Korb | Executive Officer | |
| Edward Roffman | Director | |
| Richard Cunningham | Executive Officer | |
| Clive Kabatznik | Director | |
| Michael Taglich | Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Sep 10, 2018 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Icagen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.